Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies.
Schabacker, D S
Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies. [electronic resource] - Immunology May 2000 - 48-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0019-2805
10.1046/j.1365-2567.2000.00004.x doi
Animals
Antibodies, Anti-Idiotypic--biosynthesis
Antibodies, Monoclonal--biosynthesis
Antibody Specificity
Brain--metabolism
Cocaine--immunology
Cocaine-Related Disorders--therapy
Feasibility Studies
Immunotherapy, Active--methods
Mice
Mice, Inbred BALB C
Spleen--immunology
Exploring the feasibility of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies. [electronic resource] - Immunology May 2000 - 48-56 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0019-2805
10.1046/j.1365-2567.2000.00004.x doi
Animals
Antibodies, Anti-Idiotypic--biosynthesis
Antibodies, Monoclonal--biosynthesis
Antibody Specificity
Brain--metabolism
Cocaine--immunology
Cocaine-Related Disorders--therapy
Feasibility Studies
Immunotherapy, Active--methods
Mice
Mice, Inbred BALB C
Spleen--immunology